SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medici

First Page		Document Content
Antivirals Pyrazines Telaprevir Hepatitis Ribavirin Interferon Cirrhosis Hepatocellular carcinoma Liver cancer Medicine Hepatology Health		SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medici Add to Reading List Source URL: www.scottishmedicines.org.uk Download Document from Source Website File Size: 259,20 KB Share Document on Facebook

	Acute Hepatitis C in the PROUD pilot study Juan Tiraboschi, Liz Brodnicki, Brady Michael, John Saunders, Schembri Gabriel, Mark Roche, Julie Fox on behalf of the PROUD study DocID: 1vngt - View Document
	PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno DocID: 1vlwz - View Document
	PRESS RELEASE AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes    DocID: 1vjI2 - View Document
	APASL and CEVHAP Partnership: a Hepatitis-Free World November DocID: 1vgwC - View Document
	California Institute of Technology Hepatitis B Vaccination Offer Form Occupational Exposure to Bloodborne Pathogens Please complete this form if you may come in contact with human blood or other potentially infectious hu DocID: 1vf93 - View Document